🔗 Visit the ClinicalTrials.gov page for NCT01705340
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Multidrug-resistant breast cancer: current perspectives. | Breast Cancer (Dove Med Press) | 2014 | 0.99 |
| 2 | Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. | Oncotarget | 2015 | 0.97 |
| 3 | Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer. | Biochim Biophys Acta | 2014 | 0.96 |
| 4 | Current Approaches and Emerging Directions in HER2-resistant Breast Cancer. | Breast Cancer (Auckl) | 2014 | 0.87 |
| 5 | Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review). | Mol Clin Oncol | 2013 | 0.86 |
| 6 | Personalized medicine in gastric cancer: Where are we and where are we going? | World J Gastroenterol | 2016 | 0.79 |
| 7 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists. | World J Gastroenterol | 2016 | 0.78 |